Maria J. Sebastiao

Oeiras, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Evaluation of gene editing in CHO cells using the Cas-CLOVER system.

Evaluation of gene editing in CHO cells using the Cas-CLOVER system.

Journal: Biotechnology progress
Published: November 06, 2025

Multispecific antibodies: Bioanalytics for early-stage screening and characterization of mispairing profiles.

Multispecific antibodies: Bioanalytics for early-stage screening and characterization of mispairing profiles.

Journal: PloS one
Published: February 08, 2025

Controlled activation modulates T-cell expansion and phenotype in stirred-tank bioreactors.

Controlled activation modulates T-cell expansion and phenotype in stirred-tank bioreactors.

Journal: Cytotherapy
Published: January 08, 2025

Miniaturization of hiPSC-derived 3D neural cultures in stirred-tank bioreactors for parallelized preclinical assessment of rAAV.

Miniaturization of hiPSC-derived 3D neural cultures in stirred-tank bioreactors for parallelized preclinical assessment of rAAV.

Journal: Frontiers in bioengineering and biotechnology
Published: January 31, 2024

Identification of Mispairing Omic Signatures in Chinese Hamster Ovary (CHO) Cells Producing a Tri-Specific Antibody.

Identification of Mispairing Omic Signatures in Chinese Hamster Ovary (CHO) Cells Producing a Tri-Specific Antibody.

Journal: Biomedicines
Published: September 15, 2023

Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction.

Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction.

Journal: Biomedicines
Published: October 24, 2022

Stem cells characterization: OMICS reinforcing analytics.

Stem cells characterization: OMICS reinforcing analytics.

Journal: Current opinion in biotechnology
Published: January 30, 2021

Proteomic and Glyco(proteo)mic tools in the profiling of cardiac progenitors and pluripotent stem cell derived cardiomyocytes: Accelerating translation into therapy.

Proteomic and Glyco(proteo)mic tools in the profiling of cardiac progenitors and pluripotent stem cell derived cardiomyocytes: Accelerating translation into therapy.

Journal: Biotechnology advances
Published: August 01, 2020

Bioreactor-based 3D human myocardial ischemia/reperfusion in vitro model: a novel tool to unveil key paracrine factors upon acute myocardial infarction.

Bioreactor-based 3D human myocardial ischemia/reperfusion in vitro model: a novel tool to unveil key paracrine factors upon acute myocardial infarction.

Journal: Translational research : the journal of laboratory and clinical medicine
Published: April 29, 2019

Human cardiac progenitor cell activation and regeneration mechanisms: exploring a novel myocardial ischemia/reperfusion in vitro model.

Human cardiac progenitor cell activation and regeneration mechanisms: exploring a novel myocardial ischemia/reperfusion in vitro model.

Journal: Stem cell research & therapy
Published: January 30, 2019

Human cardiac stem cells inhibit lymphocyte proliferation through paracrine mechanisms that correlate with indoleamine 2,3-dioxygenase induction and activity.

Human cardiac stem cells inhibit lymphocyte proliferation through paracrine mechanisms that correlate with indoleamine 2,3-dioxygenase induction and activity.

Journal: Stem cell research & therapy
Published: August 09, 2018

Definition of a cell surface signature for human cardiac progenitor cells after comprehensive comparative transcriptomic and proteomic characterization.

Definition of a cell surface signature for human cardiac progenitor cells after comprehensive comparative transcriptomic and proteomic characterization.

Journal: Scientific reports
Published: April 26, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026